Market Overview

UPDATE: Wedbush Securities Reiterates Neutral Rating, Raises PT on CIGNA Corporation

Share:
Related CI
Goldman Adds Cigna To Conviction Buy List, Expects DoJ Announcement To Refocus Investors On Standalone Merits
Barron's Picks And Pans: Madison Square Garden, Cigna, Kennedy-Wilson And More
Week In Review: Stock Breakouts, Netflix Subs Snub, Tesla's Plan, M&A News (Investor's Business Daily)

In a report published Friday, Wedbush Securities reiterated its Neutral rating on CIGNA Corporation (NYSE: CI), and raised its price target from $53.00 to $57.00.

Wedbush noted, “Three of the 4 largest health plans now looking for commercial enrollment pressures in 2013, anticipate similar comments from WLP next week. United and Aetna both indicated there could be commercial enrollment losses, CIGNA is expecting around 2% declines in the national account segment (employers >5K and multi-state). All three companies are pointing towards a shrinking market driven by continued high unemployment, Aetna and United pointed to continued competitiveness in the market. CIGNA could see some benefit over peers driven by high retention levels.”

CIGNA Corporation closed on Thursday at $53.27.

Latest Ratings for CI

DateFirmActionFromTo
Jun 2016Stifel NicolausInitiates Coverage onBuy
Feb 2016BMO CapitalMaintainsOutperform
Feb 2016BarclaysMaintainsEqualweight

View More Analyst Ratings for CI
View the Latest Analyst Ratings

Posted-In: Wedbush SecuritiesAnalyst Color Price Target Analyst Ratings

 

Related Articles (CI)

View Comments and Join the Discussion!